Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01WWD
|
|||
| Former ID |
DIB005897
|
|||
| Drug Name |
KPS-0373
|
|||
| Synonyms |
S-0373; TSH release modulator (spinocerebellar ataxia), Kissei; Thyrotropin-releasing hormone derivative (spinocerebellarataxia), Shionogi; Thyrotropin-releasing hormone derivative (Parkinson's disease), Shionogi
Click to Show/Hide
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 3 | [1] | |
| Company |
Shionogi & Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thyrotropin-releasing hormone (TRH) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01970111) An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD). U.S. National Institutes of Health. | |||
| REF 2 | DOI: 10.1002/mdc3.12057 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.